Home » Topics » Nephrology, BioWorld Science

Nephrology, BioWorld Science
RSS

Merck & Co. pursues alpha1a-adrenoceptor antagonists for BPH

Feb. 5, 1997

New SOD-CAT mimetic shows potential in situations of acute ischemia-reperfusion

Jan. 29, 1997

Kotobuki discloses muscarinic antagonists

Jan. 27, 1997

New alpha1-adrenoceptor antagonists from Roche

Jan. 24, 1997

Ibopamine efficacy in patients with chronic progressive renal failure

Jan. 20, 1997

Mayo Foundation reports new natriuretic peptide

Jan. 20, 1997

MedCare opens new U.S. treatment centers for urinary incontinence

Jan. 10, 1997

Positive phase III trial results reported for phosphate binder

Jan. 9, 1997

P&U files for European approval of urinary incontinence Rx

Jan. 9, 1997

Watson's first NDA product approved

Jan. 3, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 30, 2026.
Brain-derived tau in blood predicts stroke severity and outcome
BioWorld Science
Brain-derived tau, a protein that is exclusive to the brain and detectable in the blood, could serve as an indicator of brain damage after an ischemic stroke. The...
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...